Abstract
During the progression of chronic kidney disease (CKD), the retention of uremic toxins plays a key role in the development of uremic syndrome. Knowledge about the nature and biological impact of uremic toxins has grown exponentially over the past decades. However, the science on reducing the concentration and effects of uremic toxins showed few advancements. However, innovative approaches are in the pipeline.
Chairs
- Joachim Jankowski
- Griet Glorieux
The programme
Time | Presentation |
|---|---|
WelcomeGriet Glorieux and Joachim Jankowski | |
30 min | Keynote talkWearable artificial kidney and uremic toxin removalDimitrios Stamatialis, University of Twente, The Netherlands |
13 min | Drug-Toxin Interactions At Organic Anionic Transporter 1: Implications For Bioartificial Kidney DevelopmentSilvia Mihăilă, Utrecht University, The Netherlands |
13 min | An on-line optical sensor for monitoring of the removal of prototypical uremic toxins from the blood during haemodialysisJana Holmar, Tallinn University of Technology, School of Information Technologies, Department of Health |
13 min | The duality of uremic toxicityGriet Glorieux, Ghent University Hospital, Belgium |
13 min | Prevention of post-translational modifications by free amino acid supplementationJoachim Jankowski, RWTH Aachen, Germany |
Closing wordsGriet Glorieux and Joachim Jankowski |